Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factorH O Heuer, J Casals-Stenzel, G Muacevic, et al.Agents and Actions. Supplements|January 1, 1991
The effects of hetrazepine PAF antagonists in preclinical models of asthmaH O HeuerJournal of Lipid Mediators|July 1, 1991
WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigsH O HeuerEuropean Journal of Pharmacology|June 25, 1991
Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170)H O HeuerJournal of Lipid Mediators|November 1, 1991
PAF receptor antagonists influence asphyxia-induced changes of the inner earA Ernst, H O HeuerArzneimittel-Forschung|August 1, 1992
Platelet-activating factor antagonists in experimental shockG Muacevic, H O HeuerNaunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1991
Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and ratsH O Heuer, B Keller, K UrichJournal of Lipid Mediators|January 1, 1990
Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivoH O Heuer, G Letts, C J MeadePageof 4